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Abstract 
The newly developed deep-sequencing technologies make it possible to acquire both quantitative 
and qualitative information regarding transcript biology.  By measuring messenger RNA levels 
for all genes in a sample, RNA-seq provides an attractive option to characterize the global 
changes in transcription.  RNA-seq is becoming the widely used platform for gene expression 
profiling. However, real transcription signals in the RNA-seq data are confounded with 
measurement and sequencing errors, and other random biological/technical variation. How to 
appropriately take the variability due to errors and sequencing technology variation into account 
is essential issue in the RNA-seq data analysis. To extract biologically useful transcription 
process from the RNA-seq data, we propose to use the second ODE for modeling the RNA-seq 
data.  We use differential principal analysis to develop statistical methods for estimation of 
location-varying coefficients of the ODE.    We validate the accuracy of the ODE model to fit the 
RNA-seq data by prediction analysis and 5 fold cross validation. We find the   accuracy of the 
second ODE model to predict the gene expression level across the gene is very high and the 
second ODE model to fit the RNA-seq data very well. To further evaluate the performance of the 
ODE model for RNA-seq data analysis, we used the location-varying coefficients of the second 
ODE as features to classify the normal and tumor cells. We demonstrate that even using the ODE 
model for single gene we can achieve high classification accuracy. We also conduct response 
analysis to investigate how the transcription process respond to the perturbation of the external 
signals and identify dozens of genes that are related to cancer.    
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1. Introduction 
    Next Generation Sequencing (NGS) technologies have revolutionized advances in the study of 
the transcriptome. The newly developed deep-sequencing technologies make it possible to 
acquire both quantitative and qualitative information regarding transcript biology.  By measuring 
messenger RNA levels for all genes in a sample, RNA-seq provides an attractive option to 
characterize the global changes in transcription.   
     To generate RNA-seq data, the complete set of mRNA are first extracted from an RNA 
sample and then shattered and reverse transcribed into a library of cDNA fragments with 
adaptors attached. These short pieces of cDNA are amplified by polymerase chain reaction and 
sequenced by machine, producing millions of short reads. These reads are then mapped to a 
reference genome or reference transcript. The number of reads within a region of interest is used 
as a measure of abundance.  The reads can also be assembled de novo without the genomic 
sequence to create a transcription map. 
Compared to microarray which provides limited gene regulation information, RNA-seq offers 
a comprehensive picture of the transcriptome. RNA-seq has made a number of significant 
qualitative and quantitative improvements on gene expression analysis and provides multiple 
layers of resolutions and transcriptome complexity:  the expression at exon, SNP, and positional 
level; splicing; post-transcriptional RNA editing across the entire gene; isoform and allele-
specific expression [1].  
Many advantages include strong concordance between platforms, higher sensitivity and 
dynamic range, lower technical variation and background signal, and high level of technical and 
biological reproducibility, and so on [2-5].  However, some limitations are inherent to next-
generation sequencing technology. For example, the read coverage may not be homogeneous 
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along the genome, and different samples may be sequenced at different levels of depth in the 
experiment. Also, although some genes may have a similar level of expression, longer genes are 
more likely to have more reads than short ones. Therefore, RNA-seq data must be normalized 
before any comparison of the counts can be made. Another consideration is that in production of 
cDNA libraries, larger RNA must be fragmented into smaller pieces to be sequenced and 
different fragmentations may create bias toward different outcomes. Some other informatics 
challenges like the storage, transfer, and retrieval of large size data which may bring additional 
errors [6, 7].   
Expression variability measured by RNA-seq arises from three primary sources: (i) real 
biological differences in different experimental groups or conditions, (ii) measurement errors and 
(iii) random biological and/or technical variation [1, 8]. The first type of variability is of real 
biological interest, but is confounded with measurement and sequencing errors, and other 
random biological/technical variation. How to appropriately take the latter two types of 
variability into account is essential issue in the RNA-seq data analysis.     
Purpose of this paper is to borrow dynamic theory from engineering and use ordinary 
differential equation (ODE) for modelling the observed number of reads across the gene and 
unravelling the features of gene transcription [9]. To achieve this goal, we considered the number 
of reads or expression level at each position as a function of the genomic position and viewed the 
transcription process as a stochastic process of transcription along the genome. Instead of taking 
the derivative of expression level with respect to time, we calculated the expression level 
derivative with respect to genomic position. Specifically, we proposed a dynamic model for the 
variation of the transcription process along the genome. For each gene, we use a second-order 
ODE with location-dependent coefficient to model that gene’s transcription process. We develop 


statistical methods for estimation of the coefficient functions in the ODE based on principal 
differential analysis.  Compared to the ODE model with constant coefficient to capture the 
stochastic variation feature of transcription process, the location-dependent coefficients are 
essential to account for the complicated stochastic process of gene regulation.  
To examine the precision of the ODE for modeling the RNA-seq data, we split the samples 
into five groups and use 5 fold cross validation to evaluate the accuracy of the predicting gene 
expression level across the gene using the ODE model. 
    To capture stochastic feature of gene regulation, we conduct the response analysis. The 
response analysis of transcriptional processes for each gene using its fitted differential equation 
can provide important aspects of transcription, including alternative splicing, alternative start and 
end of transcription, and alternative isoforms. To differentiate feature of gene regulation between 
normal and cancer tissue samples, we develop statistics to test for significant difference in the 
response of the gene regulation between the normal and cancer samples under the perturbation of 
external signals and perform genome-wide response analysis of gene regulation. Using the ODE 
model, we identified the genes that have a significantly different transcriptional process (both 
different magnitude and different patterns), and identified genes that showed significantly 
differential stochastic behaviors in response to environmental perturbations between normal and 
cancer samples.  
   To further explore application of the ODE for RNA-seq data analysis, we take the location-
varying coefficients of the ODE as features and use FPCA as a tool for extraction of these 
features. The FPCA scores are used as features and the lasso logistic regression is used as feature 
selection  tool and classifier for distinguishing  the cancer and normal samples.  
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    The data suggest that the dynamic features of gene transcription captured by the coefficient 
functions can retrieve the original process information. Therefore, they are naturally served as a 
good candidate’s features for clustering genes with similar transcription process. These groups of 
genes could share common biological function, chromosomal location, pathway or regulation.  
The ODE for modeling the RNA-seq data has the potential to provide valuable information for 
understanding the mechanism of gene regulation and unraveling disease processes.  
2. Materials and Methods 
2.1  ODE model with varying coefficients for RNA-seq data.   
    Assume that the expression of a gene is measured by the number of sequence reads mapped to 
this gene in the region ],[ baT = . Let  denote a genomic position,   be observed gene 
expression level that was measured by the number of reads mapped to the genomic position and 
)(tx be the hidden state that determined the gene expression level at the genomic position t  .  To 
model transcription process, the second-order ordinary differential equation (ODE) with location 
varying coefficients can be specified as follow. 
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where  and  are weighting coefficients or parameters in the ODE.  Its observations  often have measurement errors: 
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where  is measurement error at the position	. 
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2.2 Estimation of coefficient functions in the ODE 
Estimation of coefficient functions in the ODE consists of two steps. At the first step we estimate 
the states )(ˆ tx  from the observed number of reads )(ty  assuming that coefficient functions in 
the ODE are given. At the second step, we estimate the coefficient functions in the ODE, 
assuming that states )(tx have been estimated. 
Step 1:  
To estimate )(tx  , we first expand the function 
  in terms of basis functions )(tφ and then 
estimate its expansion coefficients.  Let 
 be the state variable at the genomic position t  of 
the -th sample  and    be its observation (     ). Then, 
  can be expanded as 
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Substituting their expansions into equation (1), we obtain 
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We estimate the state function 
 from the observation data  by minimizing the following 
objective function which consists of the sum of the squared errors between the observations and 
the estimated states, and the penalty terms: 
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Problem (6) can be rewritten in a matrix form: 
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The least square estimators of the expansion coefficients are then given by 
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Step 2 
Next we estimate the coefficient functions in the ODE. The coefficient functions in the ODE can 
be estimated by minimizing the following least squares objective function: 
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Therefore, problem (8) can be reduced as  
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In summary, we iteratively determine the expansion coefficients of the state function )(tX  for 
fixed parameters in the ODE by equation (7) and estimate the coefficient functions in the ODE 
for fixed expansion coefficients by equation (11). 
2.3. ODE for classification 
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To illustrate that the ODE can be used as a useful tool for modeling the profile of the RNA-seq 
expression we will show that the ODE can capture all variation of gene expression across the 
gene and that the coefficient functions of the ODE are useful feature extraction of the RNA-seq 
data. The ODE can be used for classifying tumor and normal samples. 
Since dimensions of the coefficient functions of the ODE are extremely high, the functional 
principal component analysis (FPCA) is used to reduce the dimensions of the coefficient 
functions of the ODE.  
The FPCA  tries to find the dominant direction of variation around an overall trend function [10, 
11] Each principal component is specified by the weight function )(tβ , and the principal 
component scores of the individuals in the sample are defined as the inner product of weight 
function and functional curves ( )(),( 10 twtw ). 
∫= T dttwtz )()(β , 
where for convenience, we use )(tw  to denote either )(1 tw or )(0 tw .That is the coordinate value 
of functional curves at the direction of	. with highest variability. By projecting the functional 
curves onto set of eigenfunctions, we can reduce the dimension to finite number, functional 
principal component scores.    
Suppose that for the i -th individual sample we obtain the functional principal component score: 
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where  )(1 twi and )(0 twi are the coefficient functions of the ODE for he i -th individual sample, 
and Kjtj ,...,1),( =β are a set of eigenfunctions (or principal component functions). The original 
functional curves can be reduced to a finite feature matrix: 
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where the K is the number of principal components selected to explain the total variability.  
To improve classification accuracy we use the LASSO logistic regression as a classifier. In 
simple logistic regression, we use the logit link to relate the mean of response with the covariates 
of interest.  Let 
  /
   0,1 be the vector of observed covariates for ith observation, and 	 
is the corresponding response outcome. For simplicity, we consider binary cases where	 	23	4. The model is specified as the following posterior probability for th observation[12]. 
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where 	8  /.   .,1is the covariate vector of   interest, and .  is the intercept term. And the 
joint log-likelihood of the N subjects is defined as 
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To estimate the parameter, we set its derivatives to zero and get the score equations 
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Since (12) is nonlinear equations in	., we usually use some iterative methods like Newton-
Raphson algorithm to get the solution of	..  
By adding a & penalty to the joint log-likelihood in equation (12) we have the following 
constrained maximization equation  
 @O8  PAI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             (13) 
@O8		is the constrained log-likelihood and $	 is tuning parameter to adjust the tradeoff between 
log-likelihood function and  the size of penalty. Please note that in Lasso, we usually do not 
penalize the intercept term and it is practical meaningful to standardize the covariates before 
optimization. 
The & penalty is not differentiable and also 8 is not linear solution of response y. It is not trivial 
to get the score functions but we can still have a solution using nonlinear programming method 
[13]. The score functions for variables with non-zero coefficients have the form  
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Coordinate descent method is one efficient method to compute the Lasso solution. It fixes the 
penalty parameters $ and optimize over each parameter successively, while holding the others 
fixed at current values. R package glmnet [14] can efficiently fit the Lasso logistic regression 
with large [ and	\. 
2.4 Numerical solution to the ODE with bounded values. We use collocation Runge-Kutta 
method for the solution of boundary value problem of the ODE. The basic idea is to find a set of 
polynomials )(xpn  of degree s which satisfies the problem over the interval [ nn xx ,1− ] for a set 
of points 
njnnj haxx += −1 , where  sj ,...,1=  and Nn ,...,1=  
Note that 1...0 10 <<<<< saaa , they are distinct real numbers. Also the polynomial functions 
)(xpn  are set to satisfy 
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The numerical approximation at nx  is given by  
)( 1 nnnn hxpy += −  
R package bvpSolve implements the method for boundary value problem [15].  
2.5 Response analysis under perturbation of external signal. 
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    Gene regulatory properties are encoded in the parameter curves of the ODE modeling gene 
expressions. Testing significant difference in the parameter curves between two conditions can 
be used as a powerful tool to assess differential changing behaviors of the gene expression across 
the gene region between two conditions. Response analysis attempts to extract inherent features 
of the systems that capture and describe the behaviors of the system over genomic positions 
under different operating conditions and perturbation of external signals.  
Let  denote a genomic region within the gene of interests and 
 be the number of 
reads mapped to the genomic region. And the ODE model used to describe the expression profile  
is given as follow 
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Suppose the 	_  and 	_  are estimated from the data. The response of a regulatory system 
depends on the input signals. Different signal will cause different responses. For simplicity, we 
consider unit-step signal forced on the system and then solve the responses of the original system 
between different groups using estimated parameters 	_   and	_ . 
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    To solve the solution of the estimated ODE with unit-step force function	`, we have to use 
some numerical methods to approximate the solution	
a.  We solved ODE numerically by 
considering two-point boundary value problems where boundary conditions are specified at both 
ends of the range of integration. We estimated two initial values at both ends by evaluating the 
estimated smoothing expression curves at start and end positions. 
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Suppose b  3 3^    3Cc  be a vector-valued function to represent 
response functional for all [ subjects in the normal group and	*  d d^   dCe 
be response functional for [^ subjects in cancer group. Therefore, we can construct a Hotelling  f^.  Suppose that the response functions were expanded in terms of  eigenfunctions 
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Where ∫= T jiij dtttr )()( φξ  and ∫= T jiij dttts )()( φη , ijξ  and ijη are uncorrelated random variables 
with zero mean and variances jλ with ∞<∑
j
jλ . Define the averages jξ and jη of the principal 
component scores ijξ and ijη in the normal and cancer group. Then we denote the average vector 
of scores in normal and cancer group by 
g̅  gi  gji  k̅  klll  kjlll 
where gmi  Cc∑ gCc  and  kmi  Ce∑ kCe , n    o 
The pooled covariance matrix is  
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Let s   Cc # Ce*, then the Hotelling statistics  can be written as f^ 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

Under null of no difference in the response of the gene regulation between two groups, the 
statistics follows uj^  distribution where k  is the number of principle component scores.  
3. Results 
3.1 Dataset. We apply the proposed model to Kidney Renal Clear Cell Carcinoma (KIRC) RNA-
seq data, which is available from The Cancer Genome Atlas (TCGA) project (https://tcga-
data.nci.nih.gov/tcga/). The RNA-seq data is available for 72 matched pair of KIRC and normal 
samples. The maximum number of genomic positions where the expressions were measured by 
the number of reads passing qualify of control is 382,239,893 in the raw BAM file. And the total 
number of genes is 19,717.  
Samtools and bedtools were applied to count number of reads for each base of the gene. Effected 
mapping reads was taken as the scale factor to normalize the reads for each individual. Hg19 
human genome was taken as the reference. 
Illumina paired-end RNA sequencing reads were aligned to GRCh37-lite genome-plus-junctions 
reference using BWA version 0.5.7. This reference combined genomic sequences in the 
GRCh37-lite assembly and exon-exon junction sequences whose corresponding coordinates were 
defined based on annotations of any transcripts in Ensembl (v59), Refseq and known genes from 
the UCSC genome browser, which was downloaded on August 19 2010, August 8 2010, and 
August 19 2010, respectively. Reads that mapped to junction regions were then repositioned 
back to the genome, and were marked with 'ZJ:Z' tags. BWA is run using default parameters, 
except that the option (-s) is included to disable Smith-Waterman alignment. Finally, reads 
failing the Illumina chastity filter were flagged with a custom script, and duplicated reads were 
flagged with Picard's MarkDuplicates. 
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In order to make the data comparable, we applied log transformation on the observed expression 
profiles. Some genomic position has zero counts and we intentionally add 1 to it and then it 
returns to be zero after log transformation.  After that expression counts for most of genes are of 
the same scale. We also mapped the genes onto the interval [0,100]. 
3.2. Evaluation of the ODE for modeling RNA-seq data.  
To evaluate the precision of the ODE for modeling the RNA-seq data, we first used the ODE to 
fit the RNA-seq data where the coefficient functions were estimated. Then, we used numerical 
collocation Runge-Kutta method to solve the fitted ODE. The solutions of the fitted ODE as a 
function of genomic position were then compared with the observed RNA-seq curves.  
We estimated the varying-coefficient functions using the proposed model. The expression 
function for gene 0 was first estimated by spline smoothing with some initial penalty. We 
then update the penalty using the proposed second order ODE with varying-coefficient functions. 
We iterated between curve smoothing and ODE estimation until convergence was achieved. The 
smoothing parameters $ were chosen by cross-validation process.  By selecting the value of		$, 
we trade off basis expansion fitting error and ODE solution filtering error. Larger value of $ put 
more emphasis on the ODE penalty and the solution to ODE with estimated parameters are more 
likely to approximate the original data.   
To validate the estimates of coefficients functions in the model, it is essential to compare the 
observed gene expression curve to the ODE solution with estimated coefficient functions. We 
solved ODE numerically by considering two-point boundary value problems where boundary 
conditions are specified at both ends of the range of integration. We estimated two initial values 
at both ends by evaluating the estimated smoothing expression curves at start and end positions. 
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Figures 1A and 1B are fitted results of normal sample and cancer sample respectively for gene 
CD74. In these figures, the circles represent observed RNA-seq expression signal (green: normal; 
red: cancer); the blues lines are Fourier basis expansion to approximate the observed signal using 
weighted least square methods. The numbers of basis are chosen based on the length of genes 
and experimental adjustment to capture the important characteristics of gene expression curves. 
The dashed lines are estimated ODE solution using boundary value problem solver (R package 
bvpSolve).   The ODE solutions approximate well the observed expression level of gene CD74, 
which show that estimated coefficient functions carry essential information of the original data. 
Once we have them, we can retrieve the original data very well.  
To further evaluate the precision of the ODE for modeling RNA-seq data, we perform 5-fold 
cross-validation prediction for gene RPL29.  This method uses part of the available data to fit the 
model and estimate the parameters, and uses the remaining data to test the model validity and 
estimate accuracy. We randomly split normal and cancer samples into 5 folds. From the 
estimation of parameters in the training samples, we solved the ODE with estimated coefficient 
functions to predict the expression curves of test samples.  To be consistent, we estimated two 
initial values at both ends by evaluating the estimated smoothing expression curves at start and 
end positions in test samples. We also calculated the root mean square prediction error (RMSPE) 
for each folder to evaluate the performance of the prediction which is defined by 
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Where  and a are observed and predicted expression level;  [ is the number of genomic 
positions where the RNA-seq are observed for the gene and  [ is the number of subjects in the 
folder j. 
 The table 1 lists RMSPE in each folder for normal and cancer groups. The normal group has 
slightly better performance in terms of prediction on the test samples. But both prediction errors 
are relatively small. 
Figures 2A and 2B are prediction results for selected samples in test set for gene RPL29 in 
normal and cancer group respectively. The gray dot is observed expression profile, and the solid 
red lines are Fourier basis expansion approximations to the observed expression data. The dashed 
green lines indicate the predicted gene expression profile in the test set by solving the estimated 
ODE in the training examples. We can observe that all of the prediction can capture the overall 
shape and fluctuation in the data. Secondly, they can also predict the magnitude of expression 
value with decent accuracy. These are predicted very close to the observed expression profiles. 
3.3 Classification analysis. 
These data suggest that the estimated coefficient functions capture important features of 
expression curves. From the solution to estimated ODE, we can see the exceptional retrieval of 
original data. From the prediction performance in the test set, we can also get well predicted 
curves by just proving two initial boundary data points.  It is natural to consider them as features 
to classify phenotype categories.  
     We obtain two coefficient functions from one expression function. We can use FPCA to help 
us to reduce the dimension of features and to ease the computational effort. We first applied 
FPCA technique on two coefficient functions 		 and 		   separately, then we combined 
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two groups of the selected functional principal component scores as aggregated features before 
we provided them to classifier. In the end, we applied lasso logistic regression to help us select 
features and make prediction on the groups.    
The table 2 lists top 12 genes to differentiate normal and KIRC group using 5 fold cross-
validations. We can see that using a single gene it can reach as high as 90% classification 
accuracy. These data strongly indicate that the ODE model effectively captured the inherent 
features of RNA-seq expression profile. We also evaluated the performance of classification 
result using sensitivity, specificity and accuracy. Sensitivity is defined as the percentage of 
cancer tissues correctly classified as cancer. Specificity is defined as the percentage of the 
normal tissues correctly classified as normal. The classification accuracy is defined as the 
percentage of the correctly classified normal and cancer tissues.  The classification results can be 
reached as high as 99% if we use all these 12 genes together as predictors. 
3.4 Genome-scale clustering analysis. 
In this section, we continue to use the estimated coefficient functions as features to cluster genes 
expression data to study the genome wide transcriptome.  By grouping genes with similar 
patterns of expression profiles, cluster analysis can provide insight into gene functions and 
biological process. It also gives a simple way of determining the functions of many genes for 
which information is not available, as genes with same functions may share expression profiles.  
We assume the coefficient functions in ODE model help to define these patterns in the dynamic 
regulation process and give us clues to functional discovery and pattern grouping. 
    After we derive the feature matrix for all the genes from dimension reduction using FPCA, we 
merely need to adopt a metric definition which is used as a measure of similarity in the behavior 


of two genes. To calculate the distance matrix we used Euclidean distance and correlation matrix. 
This method computes a dendrogram that combine all genes in a single tree.  
    A total of 19717 genes were clustered into 9 groups according to the cluster analysis (Figures 
3A and 3B). The functional principal component scores from coefficient functions in ODE 
model were used as significant features to define these patterns in the dynamic regulation process. 
The function annotation for each cluster was as the following.  
    The principle functions of the genes in the first group are mainly associated with 
oxidoreductase activity, ligase activity, dehydrogenase (NAD) activity and related metabolic 
process. The detail functions include aldehyde dehydrogenase (NAD) activity, translational 
initiation, mediator complex, MHC protein complex, mitochondrial membrane part, ion 
transmembrane transport, respiratory chain complex I, proton-transporting ATP synthase 
complex, proton-transporting two-sector ATPase complex, proton-transporting domain, NADH 
dehydrogenase (quinone) activity, oxidoreductase activity, acting on the aldehyde or oxo group 
of donors, NAD or NADP as acceptor, positive regulation of protein ubiquitination, response to 
unfolded protein, heterocycle metabolic process, protein modification process, mitochondrial 
ATP synthesis coupled proton transport, glycerolipid metabolic process, macromolecule 
modification, proton-transporting two-sector ATPase complex, catalytic domain, regulation of 
translational initiation, oxidoreductase activity, acting on the aldehyde or oxo group of donors, 
RNA polymerase II transcription mediator activity, heme binding, positive regulation of ligase 
activity, negative regulation of ligase activity, negative regulation of ubiquitin-protein ligase 
activity involved in mitotic cell cycle, positive regulation of ubiquitin-protein ligase activity 
involved in mitotic cell cycle, regulation of ubiquitin-protein ligase activity involved in mitotic 
cell cycle, positive regulation of ubiquitin-protein ligase activity, negative regulation of 

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ubiquitin-protein ligase activity, transferase activity, glycerolipid biosynthetic process, amine 
transport, phosphoinositide metabolic process, carboxylic acid transport, hormone binding, 
eukaryotic translation initiation factor 3 complex, glycerophospholipid metabolic process, 
helicase activity, response to protein stimulus, lipid biosynthetic process, phosphoinositide 
biosynthetic process, aldehyde dehydrogenase [NAD(P)+] activity, proton-transporting ATP 
synthase complex, coupling factor F(o), cytosolic part, nucleobase, nucleoside and nucleotide 
metabolic process, proton-transporting ATPase activity, rotational mechanism, phospholipid 
metabolic process, phosphorus metabolic process, phosphate metabolic process, hydrogen-
exporting ATPase activity, phosphorylative mechanism, proton-transporting V-type ATPase 
complex, MHC class II protein complex, collagen, positive regulation of protein modification 
process and post-translational protein modification.  
    The principle functions of the genes in the second group are mainly associated with hydratase 
activity, cation transmembrane transporter activity and hydrolase activity and related metabolic 
process. The detail functions include NAD or NADH binding, peroxisomal membrane, 
microbody membrane, aconitate hydratase activity, 4 iron, 4 sulfur cluster binding, regulation of 
vesicle-mediated transport, lactate dehydrogenase activity, L-lactate dehydrogenase activity, 
long-chain fatty acid-CoA ligase activity, fatty acid ligase activity, homophilic cell adhesion, 
tight junction, cation transmembrane transporter activity, occluding junction, kinesin complex, 
microbody part, peroxisomal part, actin filament binding, hydrolase activity, hydrolyzing O-
glycosyl compounds, hydrolase activity and acting on glycosyl bonds. 
    The principle functions of the genes in the third group are mainly associated with 
monooxygenase activity, receptor activity, electron carrier activity, sodium ion transmembrane 
transporter activity and related metabolic process The detail functions include nucleoside binding, 
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purine nucleoside binding, monooxygenase activity, receptor activity, protein binding, ATP 
binding, DNA packaging, chromatin assembly or disassembly, electron carrier activity, sodium 
ion transmembrane transporter activity, actin cytoskeleton, RNA metabolic process, adenyl 
nucleotide binding, GTPase regulator activity, regulation of lipid transport, negative regulation 
of lipid transport, adenyl ribonucleotide binding, protein-DNA complex, very-low-density 
lipoprotein particle, triglyceride-rich lipoprotein particle, cellular nitrogen compound metabolic 
process, cellular macromolecule biosynthetic process, nucleosome organization, chylomicron, 
organelle, intracellular organelle, cellular biosynthetic process, keratin filament, regulation of 
transcription, regulation of biological process, regulation of cellular process, regulation of 
nitrogen compound metabolic process, regulation of RNA metabolic process, regulation of 
macromolecule metabolic process, nucleoside-triphosphatase regulator activity, biological 
regulation, DNA conformation change and regulation of primary metabolic process. 
    The principle functions of the genes in the fourth group are mainly associated with acyl-CoA 
thioesterase activity, oxidoreductase activity, phosphatase activity and related metabolic process. 
The detail functions include organellar small ribosomal subunit, organellar large ribosomal 
subunit, phospholipid-translocating ATPase activity, glutathione transferase activity, receptor 
signaling protein serine/threonine kinase activity, transmembrane receptor activity, inward 
rectifier potassium channel activity, organic acid transmembrane transporter activity, 
mitochondrial matrix, mitochondrial large ribosomal subunit, mitochondrial small ribosomal 
subunit, cytosol, translation, translational elongation, cell surface receptor linked signaling 
pathway, large ribosomal subunit, small ribosomal subunit, integral to membrane, acyl-CoA 
thioesterase activity, oxidoreductase activity, acting on NADH or NADPH, phosphatase activity, 
cytosolic ribosome, signaling process, signal transmission, intrinsic to membrane, negative 
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regulation of protein ubiquitination, cullin-RING ubiquitin ligase complex and mitochondrial 
lumen. 
    The principle functions of the genes in the fifth group are mainly associated with cell 
projection part, microtubule associated complex, motor activity, microtubule, axoneme, 
microtubule-based process, microtubule-based movement, microtubule cytoskeleton, dynein 
complex, cytoskeletal part, cilium, macromolecular complex, cilium axoneme, cell projection, 
protein complex, cilium part, pyrophosphatase activity, hydrolase activity, acting on acid 
anhydrides, hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides, 
nucleoside-triphosphatase activity. 
     The principle functions of the genes in the sixth group are mainly associated with intracellular 
signal transduction, cholesterol efflux, UDP-galactosyltransferase activity and histone 
demethylase activity. 
    The principle functions of the genes in the seventh group are mainly associated with ATP-
binding cassette (ABC) transporter complex, JNK cascade, ATP-dependent peptidase activity, 
    The principle functions of the genes in the eighth group are mainly associated with glutamate 
receptor activity, ATPase activity, coupled, cytoskeletal protein binding, myosin filament, 
The principle functions of the genes in the ninth group are mainly associated with 
adrenoceptor activity, inhibition of adenylate cyclase activity by G-protein signaling pathway, 
adenosine deaminase activity, hydrolase activity, acting on carbon-nitrogen (but not peptide) 
bonds, in cyclic amidines, deaminase activity, adenylate cyclase activity, activation of protein 
kinase A activity, alpha-adrenergic receptor activity, adrenergic receptor binding, epinephrine 
binding, regulation of norepinephrine secretion, norepinephrine transport, positive regulation of 
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blood pressure, norepinephrine secretion, oxidoreductase activity, acting on CH-OH group of 
donors, oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as 
acceptor and delayed rectifier potassium channel activity. 
3.5 Response analysis of gene regulation. 
     The expression level of a gene measured by sequencing can be viewed as a curve or function 
of genomic position. The gene expression will vary across the gene region. If we treat time and 
space position as the same argument, all theory and methods of dynamic system can be applied 
to RNA-seq data analysis.  The dynamic behavior of a system is encoded in the temporal 
evolution of its states or in the genomic location evolution of the gene expression in our problem. 
Therefore, borrowing dynamic theory, we can study the location-dependent variation of gene 
expression under the perturbation of the external signals.  The transient response of the dynamic 
systems is an important property of the system itself. It can be used to quantify the space domain 
characteristics of the gene regulation system responding to the disturbance of environments. Our 
goal is to investigate how the gene expression level at each genomic position varies in response 
to the external perturbation and whether this will affect the function of cell.  
We conducted response analysis of 19,717 genes under unit-step signal perturbation. We used 
the Hoteling 2T  statistic that was described in Section 2.5 to identify 31 genes that showed 
significant difference in the response property. The names of 31 genes with significant difference 
in response property were summarized in Table 3 . 
We present Figures 4A-D showing the average expression curves, unit-step response curves, 
the coefficient curves of the ODE of gene CD74, respectively. We observed that gene CD74 not 
only showed significant difference in gene expression and coefficient curves of the ODE, but 

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also demonstrated strong difference in the unit-step response. The changing point of gene 
expression curve and unit-step response curve occurred between 11b and 12 a where a splicing 
site is located. It was reported that CD 74 played  critical role in cancer cell tumorigenesis [16] 
and down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma [17].  
    Transient response is one of dynamic property. As Figures S1A-D shown, gene ABHD10 that 
did not show significant difference in gene expression and coefficient curves of the ODE, but 
demonstrated strong difference in the unit-step response.  
Figures 2A-D plotted the average expression curves, unit-step response curves, the coefficient 
curves   of the ODE of gene BTS2, respectively. Gene BTS2 was differentially expressed, but did 
not show significant difference in coefficient of the ODE between tumor and normal samples. 
Gene BTS2 was identified to have significant difference in the unit-step response. The pattern of 
difference in the unit-step response may mainly due to rapid changes of gene expression in the 
region close to genomic position 20. From the literature we found that BTS2 was associated with 
a number of cancers [18, 19]. 
4. Discussion 
Dominant methods in literature for RNA-seq data analysis use a single valued summary statistic 
to represent expression level of a gene. However, a single number oversimplifies complex 
expression variation pattern across a gene and ignore information on alternative splicing, isoform 
and expression level variation at the genomic position level. To extract biologically useful 
expression variation signals across gene from RNA-seq data which are confounded with the 
sequencing technology variation is a challenge, but important task. To meet this challenge, we 
have proposed to use the ODE for modeling the RNA-seq data and addressed several essential 
issues for application of the ODE model to RNA-seq data analysis. 


   The first issue is how to use the ODE for modeling the RNA-seq data. We considered the 
number of reads or expression level at each position as a function of the genomic position and 
viewed the transcription process as a stochastic process of transcription along the gene. 
Borrowing dynamic theory from engineering, we have used the second ODE to model the 
expression function of the gene measured by RNA-seq. We have employed differential principal 
analysis to develop statistical methods for estimation of location-varying coefficients of the ODE.  
    The second issue is the precision of the ODE  to model the RNA-seq data.  We randomly split 
normal and cancer samples into 5 folds. From the estimation of parameters in the training 
samples, we solved the ODE with estimated coefficient functions to predict the expression 
curves of test samples. We have showed that the accuracy of the prediction by the second ODE 
was very high and the root mean square prediction errors were quite small. 
   The third issue is how to extract useful regulatory signals from the RNA-seq data confound  
with measurement errors and sequencing technology variation. Since the second ODE can model 
RNA-seq data very well, the location-coefficient functions of the ODE may well characterize the 
features of the regulatory process and measure the impact of the gene expression on the function 
of the cells and tissues. We have demonstrated that using location-coefficient functions of the 
second ODE as features we have accurately classify the tumor and normal samples.  
The fourth issue is to explore the applications of the ODE for RNA-seq data analysis. We have 
showed that the ODE can be used as a powerful tool to study the response of the gene 
transcription to the perturbation of environments.  We have identified a number of cancer 
associated genes which showed significant difference in the response of the gene transcription 
between tumor and normal tissues, but were not differentially expressed.  
	

To our knowledge, this is the first to use the ODE for modeling the RNA-seq data and 
investigation of gene transcription process. Our results were very preliminary. The samples were 
used to validate the accuracy of the ODE model to fit the real RNA-seq data. Large-scale 
validation and experiments for evaluating the model precision are urgently needed. Although the 
response analysis of dynamic model for the transcription process can help us to study how the 
external signals affect the gene expression variation across the gene, the mechanism of the gene 
transcription variation under the perturbation of external signals are largely unknown. The 
experiments for validation the results of the response analysis of the dynamic models need to be 
performed. We are lack of consensus methods for RNA-seq data analysis.  We are facing great 
challenges in developing innovative approaches and general  framework  for RNA-seq data 
analysis.  
5. Conclusions 
In conclusion, this study propose the second ODE for modeling RNA-seq data. We have 
demonstrated that the estimated ODE can accurately predict the gene expression level across the 
gene. We have showed that the location-dependent coefficients of the ODE effectively extract 
regulatory signals from the RNA-seq confounded with the measurement errors and sequencing 
technology variation and capture the inherent features of the transcription process.  The results 
have showed that using coefficients of the ODE as features we can reach very high accuracy for 
classifying tumor and normal samples. Finally, we have demonstrated that using transient 
response analysis of dynamic system we identify 31 genes with significant differential response 
behavior between tumor and normal samples are related to cancer.    
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Table 1.  RMSPE in each folder for normal and cancer groups 
Folder list Normal RMSPE Cancer RMSPE 
1 0.23 0.97 
2 0.31 0.94 
3 0.24 0.79 
4 0.33 0.70 
5 0.30 0.73 
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Table 1.  The average sensitivity, specificity and accuracy of top 12 genes to classify normal and 
KIRC group over 5-fold cross validation. 
Genes Sensitivity Specificity Accuracy 
RBBP8 0.903 0.958 0.931 
ZFYVE16 0.903 0.958 0.931 
LOC100129034 0.889 0.944 0.917 
SLC44A2 0.931 0.903 0.917 
TTC21B 0.903 0.931 0.917 
C18orf56 0.958 0.861 0.910 
KCNJ16 0.889 0.931 0.910 
PFKP 0.917 0.903 0.910 
TMCC1 0.903 0.903 0.903 
CDK18 0.917 0.875 0.896 
SEC61G 0.903 0.889 0.896 
ST6GAL1 0.861 0.931 0.896 
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Table 3.  Genes with significantly difference in response behavior between normal and tumor 
samples. 
ABHD10 MFSD1 SDR39U1 ATP6V1D OXA1L SEC31A 
BST2 PACSIN2 SMCR8 CD74 PGAM1P5 SSR2 
DAP3 PIK3CB TM9SF2 DHX40 PITRM1 UBXN6 
EDF1 POLR2B UQCRC2 HLA-DMB PSAP VKORC1 
HSPA9 PSMB10 ZNF710 ISYNA1 MAT2A PSMB7 
PSMC4 
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Figure 1B 
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Figure 4B 
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 Figure 4D 
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Figure Legend 
Figure 1A. Estimate of expression profiles for CD74 by the ODE in a randomly selected normal 
sample. The green dotted points  were observed expression levels, the blue solid lines are Fourier 
basis expansions and the red dashed lines are numerical solution of ODE model. 
Figure 1B. Estimate of expression profiles for CD74 by the ODE in a randomly selected tumor 
sample. The red dotted points  were observed expression levels, the blue solid lines are Fourier 
basis expansions and the green dashed lines are numerical solution of ODE model. 
Figure 2A.  Predicted expression curves for normal tissues for Gene RPL29: The gray dot is 
observed expression profile, and the solid red lines are Fourier basis expansion approximation to 
the observed expression data. The dashed green lines are predicted gene expression profile in the 
test set by solving the estimated ODE in the training examples. 
Figure 2B.  Predicted expression curves for tumor tissues for Gene RPL29: The gray dot is 
observed expression profile, and the solid red lines are Fourier basis expansion approximation to 
the observed expression data. The dashed green lines are predicted gene expression profile in the 
test set by solving the estimated ODE in the training examples. 
Figure 3A.  Circular phylogram tree of 19717 gene that were clustered into nine gropus by 
Dendroscope 3.2.10. 
Figure 3B.  Detailed Circular phylogram tree of 19717 gene that were clustered into nine gropus 
by Dendroscope 3.2.10. 
Figure 4A. Average expression curves of gene CD74 in normal and tumor samples. 
Figure 4B. Average unit-step response curves of gene CD74 in normal and tumor samples. 
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Figure 4C. Average coefficient curves of the ODE for gene CD74. 
Figure 4D. Average coefficient curves of the ODE for gene CD74. 
 
 
 
